IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas

por Cleven, Arjen H. G., Suijker, Johnny, Agrogiannis, Georgios, Briaire-de Bruijn, Inge H., Frizzell, Norma, Hoekstra, Attje S., Wijers-Koster, Pauline M., Cleton-Jansen, Anne-Marie, Bovée, Judith V. M. G.
Publicado 2017

Metastatic potential of an aneurysmal bone cyst

por van de Luijtgaarden, Addy C. M., Veth, Rene P. H., Slootweg, Piet J., Wijers-Koster, Pauline M., Schultze Kool, Leo J., Bovee, Judith V. M. G., van der Graaf, Winette T. A.
Publicado 2009

Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases

por Huijts, Petra EA, Vreeswijk, Maaike PG, Kroeze-Jansema, Karin HG, Jacobi, Catharina E, Seynaeve, Caroline, Krol-Warmerdam, Elly MM, Wijers-Koster, Pauline M, Blom, Jannet C, Pooley, Karen A, Klijn, Jan GM, Tollenaar, Rob AEM, Devilee, Peter, van Asperen, Christi J
Publicado 2007

Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines

por Suijker, Johnny, Oosting, Jan, Koornneef, Annemarie, Struys, Eduard A., Salomons, Gajja S., Schaap, Frank G., Waaijer, Cathelijn J.F., Wijers-Koster, Pauline M., Briaire-de Bruijn, Inge H., Haazen, Lizette, Riester, Scott M., Dudakovic, Amel, Danen, Erik, Cleton-Jansen, Anne-Marie, van Wijnen, Andre J., Bovée, Judith V.M.G.
Publicado 2015